Michael Oumano1,2,3, Liz Russell4, Morteza Salehjahromi5, Lou Shanshan6, Neeharika Sinha7, Wilfred Ngwa1,8, Hengyong Yu5. 1. Medical Physics Program, Department of Physics and Applied Physics, University of Massachusetts Lowell, Lowell, MA, USA. 2. Landauer Medical Physics, Glenwood, IL, USA. 3. Department of Medical Physics and Radiation Safety, Rhode Island Hospital, Providence, RI, USA. 4. Neusoft Medical Systems USA, Houston, TX, USA. 5. Department of Electrical and Computer Engineering, University of Massachusetts Lowell, Lowell, MA, USA. 6. Neusoft Medical Systems, Hunnan District, Shenyang, China. 7. Department of Physics, Wentworth Institute of Technology, Boston, MA, USA. 8. Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA.
Abstract
INTRODUCTION: Gold nanoparticles (AuNPs) are visualized and quantified in a human-sized phantom with a clinical MDCT scanner. METHODS: Experiments were conducted with AuNPs between 0.00171 and 200 mgAu/mL. CT images were acquired at 80, 100, 120, and 140 kVp in a 33-cm phantom. Image contrast due to AuNPs was experimentally determined from regions of interest (ROIs) and effective linear attenuation coefficients were calculated from CT x-ray spectra with consideration of tissue attenuation. RESULTS: The typical 12-bit dynamic range of CT images was exceeded for AuNPs at 150 mgAu/mL. A threshold concentration of 0.3-1.4 mgAu/mL was determined for human visualization in 1-mm images at a typical diagnostic CTDIvol of 23.6 mGy. Optimal image contrast was also achieved at 120 kVp and verified by calculation. CONCLUSIONS: We have shown that scanners capable of reconstructing images with extended Hounsfield scales are required for distinguishing any contrast differences above 150 mgAu/mL. We have also shown that AuNPs result in optimal image contrast at 120 kVp in a human-sized phantom due to gold's 80.7 keV k-edge and the attenuation of x-rays by tissue. Typical CT contrast agents, like iodine, require the use of lower kVps for optimal visualization, but lower kVps are more difficult to implement in the clinic because of elevated noise levels, elongated scan times, and/or beam-hardening artifacts. This indicates another significant advantage of AuNPs over iodine not yet discussed in the literature.
INTRODUCTION: Gold nanoparticles (AuNPs) are visualized and quantified in a human-sized phantom with a clinical MDCT scanner. METHODS: Experiments were conducted with AuNPs between 0.00171 and 200 mgAu/mL. CT images were acquired at 80, 100, 120, and 140 kVp in a 33-cm phantom. Image contrast due to AuNPs was experimentally determined from regions of interest (ROIs) and effective linear attenuation coefficients were calculated from CT x-ray spectra with consideration of tissue attenuation. RESULTS: The typical 12-bit dynamic range of CT images was exceeded for AuNPs at 150 mgAu/mL. A threshold concentration of 0.3-1.4 mgAu/mL was determined for human visualization in 1-mm images at a typical diagnostic CTDIvol of 23.6 mGy. Optimal image contrast was also achieved at 120 kVp and verified by calculation. CONCLUSIONS: We have shown that scanners capable of reconstructing images with extended Hounsfield scales are required for distinguishing any contrast differences above 150 mgAu/mL. We have also shown that AuNPs result in optimal image contrast at 120 kVp in a human-sized phantom due to gold's 80.7 keV k-edge and the attenuation of x-rays by tissue. Typical CT contrast agents, like iodine, require the use of lower kVps for optimal visualization, but lower kVps are more difficult to implement in the clinic because of elevated noise levels, elongated scan times, and/or beam-hardening artifacts. This indicates another significant advantage of AuNPs over iodine not yet discussed in the literature.
Authors: Wolfgang Eck; Anthony I Nicholson; Hanswalter Zentgraf; Wolfhard Semmler; Sönke Bartling Journal: Nano Lett Date: 2010-07-14 Impact factor: 11.189
Authors: Priyanka Singh; Santosh Pandit; V R S S Mokkapati; Abhroop Garg; Vaishnavi Ravikumar; Ivan Mijakovic Journal: Int J Mol Sci Date: 2018-07-06 Impact factor: 5.923
Authors: Jeffrey R Ashton; Katherine D Castle; Yi Qi; David G Kirsch; Jennifer L West; Cristian T Badea Journal: Theranostics Date: 2018-02-12 Impact factor: 11.600